Panchkula
08048034422
+917696660290

Cefixime 50mg + Ofloxacin 50mg D/s

Dry Syrup by JESTYCEF-O 50 D/s

Cefixime 50mg + Ofloxacin 50mg D/s

INR 110
Phone Number

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Plot No, 2A, Third Floor, Industrial Area, Phase, 2 ,Panchkula, Haryana

Panchkula, India, 134113

Description

Jestycef-O 50 Dry Syrup is a pediatric combination antibiotic formulation designed to treat a broad range of bacterial infections that may not respond adequately to single-agent therapy. It contains cefixime, a third-generation cephalosporin, and ofloxacin, a fluoroquinolone. Together, they provide enhanced coverage against both Gram-positive and Gram-negative bacteria, offering dual action for faster and more effective control of infections. Cefixime works by inhibiting bacterial cell-wall synthesis, leading to structural breakdown and cell death. Ofloxacin complements this effect by blocking bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication. The synergy of these two mechanisms helps target mixed or resistant bacterial strains commonly encountered in respiratory tract infections, otitis media, sinusitis, bronchitis, urinary tract infections, gastrointestinal infections, and certain skin and soft-tissue infections. The formulation is provided as a flavored dry powder that must be reconstituted with clean water to form an oral suspension suitable for children who have difficulty swallowing tablets. After reconstitution, the suspension should be stored as directed and shaken well before each dose to ensure uniform drug distribution. The dosage is determined strictly by a healthcare professional based on the child’s weight, age, and the severity of infection. While effective, this combination is typically reserved for situations where first-line antibiotics may not suffice, due to the broader activity of fluoroquinolones. Common side effects may include nausea, mild diarrhea, abdominal discomfort, headache, or dizziness. Rarely, allergic reactions, rashes, or more serious adverse effects may occur, particularly in children with sensitivities to cephalosporins or quinolones. Caregivers should ensure the full course is completed even if symptoms improve early to prevent resistance and recurrence. This medication must be used strictly under medical supervision, and any unusual symptoms should be reported to a doctor promptly.

Specifications

Packing 30ml
GST 5%